Literature DB >> 8622302

Transmyocardial laser revascularization: operative techniques and clinical results at two years.

K A Horvath1, F Mannting, N Cummings, S K Shernan, L H Cohn.   

Abstract

OBJECTIVES: A new technique, transmyocardial laser revascularization, provides direct perfusion of ischemic myocardium via laser-created transmural channels. From 1993 to 1995, we have treated 20 patients (mean age 61 years, four women and 16 men) with transmyocardial laser revascularization. Preoperatively, the average angina class was 3.7. The patients were screened before the operation by a technetium sestamibi perfusion scan to identify the location and extent of their reversible ischemia.
METHODS: Operative exposure is gained via a left anterior thoracotomy. With the use of a 850-watt carbon dioxide laser, an average of 21 +/- 4 channels were created in 22 minutes with a total operative time of less than 2 hours.
RESULTS: The in-hospital mortality was two of 20 patients. Three additional patients died after discharge. After an accumulated 172 patient-months (mean follow-up 11 +/- 8 months, range 1 to 26 months), the mean angina class is I (p = 0.01). Postoperative sestamibi scans were obtained at 3, 6, and 12 months. Using the septum as a control and comparing the postoperative results with the preoperative baseline, we noted a significant improvement in perfusion particularly in the areas of reversible ischemia.
CONCLUSION: These early results indicate that transmyocardial laser revascularization is a simple operative technique that may improve myocardial perfusion and provide angina relief for patients in whom standard methods of revascularization is contraindicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8622302     DOI: 10.1016/s0022-5223(96)70381-1

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

1.  Laser to the heart in coronary artery disease.

Authors:  N Tamaki
Journal:  Int J Card Imaging       Date:  2000-08

2.  One world, one people, one surgery.

Authors:  T E Udwadia
Journal:  Surg Endosc       Date:  2001-03-13       Impact factor: 4.584

Review 3.  Transmyocardial laser revascularization versus medical therapy for refractory angina.

Authors:  Eduardo Briones; Juan Ramon Lacalle; Ignacio Marin-Leon; José-Ramón Rueda
Journal:  Cochrane Database Syst Rev       Date:  2015-02-27

4.  The prospective clinical and scintigraphic assessment of patients with preserved left ventricular systolic function after transmyocardial laser revascularisation.

Authors:  Miroslaw A Dziuk; Ana Canizales; Nidhal Ali; Hany El-Deeb; Keith E Britton; Duncan S Dymond; Stephen J Edmondson
Journal:  Int J Cardiovasc Imaging       Date:  2005-08       Impact factor: 2.357

5.  Transmyocardial revascularization ameliorates ischemia by attenuating paradoxical catecholamine-induced vasoconstriction.

Authors:  D Elizabeth Le; Eric R Powers; Jian-Ping Bin; Howard Leong-Poi; N Craig Goodman; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

Review 6.  Transmyocardial laser revascularization.

Authors:  Keith A Horvath
Journal:  J Card Surg       Date:  2008 May-Jun       Impact factor: 1.620

7.  [Transmyocardial laser revascularization and rehabilitation].

Authors:  T Kruse; H Höffken; R Moosdorf; C Bethge; B Maisch
Journal:  Herz       Date:  1997-08       Impact factor: 1.443

8.  Therapeutic angiogenesis induced by injecting hepatocyte growth factor in ischemic canine hearts.

Authors:  Takahiro Yamaguchi; Yoshiki Sawa; Yuji Miyamoto; Toshiki Takahashi; Chung Chung Jau; Ismayil Ahmet; Toshikazu Nakamura; Hikaru Matsuda
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 9.  Recent advances in ischaemic heart disease.

Authors:  M Cusack; S Redwood; J Coltart
Journal:  Postgrad Med J       Date:  2000-09       Impact factor: 2.401

10.  Transmyocardial Laser Revascularization.

Authors:  Keith A. Horvath
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.